Next Article in Journal / Special Issue
A Pilot Study to Examine the Disparities in Water Quality between Predominantly Haitian Neighborhoods and Dominican Neighborhoods in Two Cities in the Dominican Republic
Previous Article in Journal / Special Issue
Cultural Competence in Pediatrics: Health Care Provider Knowledge, Awareness, and Skills
Open AccessArticle

Genistein and Glyceollin Effects on ABCC2 (MRP2) and ABCG2 (BCRP) in Caco-2 Cells

Department of Basic Pharmaceutical Sciences, College of Pharmacy, Xavier University of Louisiana, New Orleans, LA 70125, USA
Author to whom correspondence should be addressed.
Current Address: Graduate School of Pharmaceutical Sciences, Mylan School of Pharmacy, Room 425 Mellon Hall, Duquesne University, 600 Forbes Avenue, Pittsburgh, PA 15282, USA
Academic Editors: Mark Edberg, Barbara E. Hayes, Valerie Montgomery Rice and Paul B. Tchounwou
Int. J. Environ. Res. Public Health 2016, 13(1), 17;
Received: 14 August 2015 / Revised: 14 September 2015 / Accepted: 23 September 2015 / Published: 22 December 2015
The goal of the present study was to determine the effects of glyceollins on intestinal ABCC2 (ATP Binding Cassette C2, multidrug resistance protein 2, MRP2) and ABCG2 (ATP Binding Cassette G2, breast cancer resistance protein, BCRP) function using the Caco-2 cell intestinal epithelial cell model. Glyceollins are soy-derived phytoestrogens that demonstrate anti-proliferative activity in several sources of cancer cells. 5 (and 6)-carboxy-2′,7′-dichloroflourescein (CDF) was used as a prototypical MRP2 substrate; whereas BODIPY-prazosin provided an indication of BCRP function. Comparison studies were conducted with genistein. Glyceollins were shown to inhibit MRP2-mediated CDF transport, with activity similar to the MRP2 inhibitor, MK-571. They also demonstrated concentration-dependent inhibition BCRP-mediated efflux of BODIPY-prazosin, with a potency similar to that of the recognized BCRP inhibitor, Ko143. In contrast, genistein did not appear to alter MRP2 activity and even provided a modest increase in BCRP efflux of BODIPY-prazosin. In particular, glyceollin inhibition of these two important intestinal efflux transporters suggests the potential for glyceollin to alter the absorption of other phytochemicals with which it might be co-administered as a dietary supplement, as well as alteration of the absorption of pharmaceuticals that may be administered concomitantly. View Full-Text
Keywords: drug-food interaction; genistein; glyceollin; isoflavonoids; MRP2; BCRP; phytoestrogen drug-food interaction; genistein; glyceollin; isoflavonoids; MRP2; BCRP; phytoestrogen
Show Figures

Figure 1

MDPI and ACS Style

Schexnayder, C.; Stratford, R.E. Genistein and Glyceollin Effects on ABCC2 (MRP2) and ABCG2 (BCRP) in Caco-2 Cells. Int. J. Environ. Res. Public Health 2016, 13, 17.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop